On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery", unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform to the industry. During the event, Dr. Yue Qian, Executive Director of the AIDD/CADD Platform at Viva Biotech, delivered an in-depth overview of the unique strengths of the AIDD platform, its disruptive innovations across the drug discovery process, and its three core modules—V-Scepter, V-Orb, and V-Mantle. Through a series of case studies, Dr. Qian showcased how Viva's AIDD platform acts as a transformative "enchantment" for drug R&D, offering an intelligent, efficient, and integrated approach to accelerate the discovery of novel therapeutics.
Dr. Yue Qian obtained her Bachelor's degree from Fudan University and continued her research at Yale University. Yue joined the Jorgensen lab where she worked on methodology development of the free energy perturbation calculation. After graduation, Dr. Qian worked as a computational chemist at the Broad Institute of MIT and Harvard and were actively involved in multiple novel drug discovery projects. Dr. Qian is now leading the AI and computational chemistry team at Viva Biotech and is responsible for various drug discovery projects and the development of AI algorithms.
For video replay，please provide the following details.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us